DiaMedica Therapeutics Inc.
DMAC
$3.53
-$0.01-0.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -26.12% | -20.78% | -20.19% | -24.74% | -41.72% |
| Total Depreciation and Amortization | 30.00% | 28.57% | 25.93% | 19.23% | 20.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.15% | -10.53% | -59.27% | -64.86% | -65.92% |
| Change in Net Operating Assets | 1,525.81% | 440.35% | -287.96% | -213.27% | -84.10% |
| Cash from Operations | -17.88% | -10.02% | -29.75% | -59.63% | -62.70% |
| Capital Expenditure | -4.17% | 60.38% | 74.42% | 70.45% | 70.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 147.00% | 148.38% | 186.92% | -239.03% | -257.29% |
| Cash from Investing | 146.80% | 148.14% | 186.40% | -240.29% | -258.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | -16.67% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -67.43% | -67.76% | -68.10% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -67.44% | -67.77% | -68.13% | 614,133.33% | 614,133.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -720.54% | 452.88% | 196.25% | 94.35% | -980.95% |